The IV bags market is estimated to grow at a CAGR of 5.38% to reach a market size of US$ 2,462.758 million in 2024 from US$ 1,798.424 million in 2018. IV Bags are used for delivering of fluid substances directly into the veins. The growing number of chronic diseases along with rising usage of IV Bags for delivering of the medication directly to the veins are driving the market for IV bags. Further, the rising number of healthcare centres in urban areas of many countries is expected to boost he IV Bag market during the forecast period. Moreover, the governmental influence to increase the number of blood banks along with rising need for blood storage is anticipated to be a key factor propelling the demand for IV bags in the coming years. Additionally, growing geriatric population is predicted to fuel the market. The market for IV Bags has been segmented by material type, capacity, chamber type, end user and geography. In the chamber type segment, the multi chamber IV bags is projected to grow at a significant rate owing to the easy delivering of two or more fluids at the same time. In the end user segment, hospitals are anticipated to hold a major share owing to the wide usage of IV Bags in hospitals. Geographically, North America is projected to be a significant shareholder owing to high presence of healthcare institutions in the region. Asia-Pacific is projected to grow at a substantial rate on account of the increasing construction of healthcare institutions.
DRIVERS
Growing need for blood storage
Rising number of chronic diseases
RESTRAINTS
Environment concerns due to difficult recycling
The major players profiled in the IV Bags market include Sippex, Kraton Corporation, Renolit Solmed, Alfa Laboratories, Polycine Gmbh, Haemotronic S.P.A., Baxter International Inc., Hospira Inc., Technoflex S.A., The Metrix Company, Medicopack A/S, Wipak Group, West Pharmaceutical Services Inc., and Qosina Corporation.
IV Bags Market Scope:
Report Metric |
Details |
Market size value in 2018 |
US$1,798.424 million |
Market size value in 2024 |
US$2,462.758 million |
Growth Rate |
CAGR of 5.38% from 2018 to 2024 |
Base year |
2018 |
Forecast period |
2019–2024 |
Forecast Unit (Value) |
USD Million |
Segments covered |
Material Type, Capacity, Chamber Type, End User, And Geography |
Regions covered |
North America, South America, Europe, Middle East and Africa, Asia Pacific |
Companies covered |
Sippex, Kraton Corporation, Renolit Solmed, Alfa Laboratories, Polycine GmbH, Haemotronic S.P.A., Hospira Inc., Technoflex S.A., The Metrix Company, Medicopack A/S, Wipak Group, Qosina Corporation |
Customization scope |
Free report customization with purchase |
Segmentation
The IV Bags market has been analyzed through the following segments:
By Material Type
PVC
PP
PE
By Capacity
Less than 100 ml
100-250 ml
250-500 ml
500-1000 ml
Above 1000 ml
By Chamber Type
Single Chamber
Multi Chamber
By End User
Blood Banks
Hospitals
Ambulatory Services
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Others
Frequently Asked Questions (FAQs)
Q1. What will be the IV bags market size by 2024?
A1. The IV bags market is estimated to reach a market size of US$2,462.758 million in 2024.
Q2. What are the growth prospects for IV bags market?
A2. The IV bags market is estimated to grow at a CAGR of 5.38% over the forecast period.
Q3. What is the size of global IV bags market?
A3. IV Bags market was valued at US$1,798.424 million in 2018.
Q4. Which region holds the largest market share in the IV bags market?
A4. Geographically, North America is projected to be a significant shareholder owing to the high presence of healthcare institutions in the region.
Q5. What factors are anticipated to drive the IV bags market growth?
A5. The growing number of chronic diseases along with rising usage of IV Bags for delivering the medication directly to the veins are driving the market for IV bags.
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. IV BAGS MARKET BY MATERIAL
5.1. PVC
5.2. PP
5.3. PE
6. IV BAGS MARKET BY CAPACITY
6.1. Less Than 100 ml
6.2. 100-250 ml
6.3. 250-500 ml
6.4. 500-1000 ml
6.5. Above 1000 ml
7. IV BAGS MARKET BY CHAMBER TYPE
7.1. Single Chamber
7.2. Multi Chamber
8. IV BAGS MARKET BY END USER
8.1. Blood Banks
8.2. Hospitals
8.3. Ambulatory Services
9. IV BAGS MARKET BY GEOGRAPHY
9.1. North America
9.1.1. USA
9.1.2. Canada
9.1.3. Mexico
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Spain
9.3.5. Others
9.4. Middle East and Africa
9.4.1. Saudi Arabia
9.4.2. Israel
9.4.3. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. South Korea
9.5.4. India
9.5.5. Others
10. COMPETITIVE INTELLIGENCE
10.1. Competitive Benchmarking and Analysis
10.2. Recent Investments and Deals
10.3. Strategies of Key Players
11. COMPANY PROFILES
11.1. Sippex
11.2. Kraton Corporation
11.3. Renolit Solmed
11.4. Alfa Laboratories
11.5. Polycine Gmbh
11.6. Haemotronic S.P.A.
11.7. Hospira Inc.
11.8. Technoflex S.A.
11.9. The Metrix Company
11.10. Medicopack A/S
11.11. Wipak Group
11.12. Qosina Corporation
LIST OF FIGURES
LIST OF TABLES
Sippex
Kraton Corporation
Renolit Solmed
Alfa Laboratories
Polycine GmbH
Haemotronic S.P.A.
Hospira Inc.
Technoflex S.A.
The Metrix Company
Medicopack A/S
Wipak Group
Qosina Corporation